Health Library › Conditions › Meningococcemia
Condition
Meningococcemia is a serious bloodstream infection caused by meningococcal bacteria.
Meningococcemia is a bloodstream infection caused by Neisseria meningitidis, often called meningococcal bacteria. It is also described as meningococcal septicemia or meningococcal sepsis.
The bacteria can multiply in the blood and trigger widespread inflammation. This can damage blood vessels, reduce blood flow to organs, and interfere with normal blood clotting. The condition may worsen within hours, so treatment must begin as soon as it is suspected.
Meningococcemia is related to meningococcal meningitis, which affects the lining around the brain and spinal cord. A person may have meningococcemia, meningitis, or both at the same time.
Early symptoms can resemble flu or another common infection. A rash is an important warning sign, but it may appear late or not appear at all. Do not wait for a rash before getting emergency help if someone is becoming seriously unwell.
Symptoms often begin suddenly and can become more severe quickly. The exact pattern differs between people.
Early symptoms may include:
As the infection progresses, a person may become confused, difficult to wake, or less responsive. They may have very little urine, breathing difficulty, dizziness, or fainting because their blood pressure is falling.
A red or purple rash can develop when bleeding occurs beneath the skin. The spots may not fade when pressed firmly with a clear glass. This is called a non-blanching rash. On brown or black skin, color changes may be easier to see inside the eyelids or mouth, or on the palms and soles.
The glass test cannot rule out meningococcemia. A rash may be absent, very small, or difficult to see. Seek emergency help based on the whole pattern of illness, especially rapid worsening.
Babies may show less specific signs, such as poor feeding, unusual crying, irritability, floppiness, reduced movement, difficulty waking, or a bulging soft spot on the head. A low temperature can occur instead of a fever.
Meningococcemia is caused by Neisseria meningitidis. These bacteria can live harmlessly in the nose and throat. In a small number of people, they enter the bloodstream and cause an invasive infection.
The bacteria spread through close or prolonged contact with saliva or respiratory droplets. Examples include living in the same household, kissing, or direct exposure to secretions from the nose or mouth. Brief everyday contact, such as passing someone in a shop, is not usually considered a significant exposure.
Anyone can develop meningococcemia. Risk is higher in certain situations, including:
Age, vaccination history, smoking exposure, and local outbreaks can also affect risk. Many people who become ill have no known medical risk factor.
Meningococcemia is diagnosed in hospital. Treatment usually begins as soon as the condition is suspected because waiting for test results could be dangerous.
Blood samples are taken for culture, which tries to grow and identify the bacteria. Polymerase chain reaction, or PCR, can detect meningococcal genetic material. Antibiotics like amoxicillin or doxycycline may make cultures less likely to find the bacteria, but treatment should not be delayed to improve a test result.
Other blood tests check blood-cell levels, clotting, inflammation, acidity, and how well organs such as the kidneys and liver are working. These tests help the hospital team assess severity and guide supportive care.
If meningitis is suspected, fluid from around the spinal cord may be tested using a lumbar puncture. This procedure is performed only when it is safe. It may be delayed or avoided when someone has shock, serious clotting problems, or another reason the procedure could cause harm.
No home test can confirm or safely exclude meningococcemia.
Meningococcemia requires immediate hospital treatment. Antibiotics are given into a vein to kill the bacteria. The initial antibiotic is chosen to cover meningococcal infection quickly and may be adjusted when laboratory results are available.
Supportive treatment protects the body while the antibiotics work. Depending on severity, this may include:
People with shock, breathing failure, or major organ problems are usually cared for in an intensive care unit. Damaged skin and tissues may need specialist wound care. Surgery is sometimes required if blood flow loss causes severe tissue damage.
Hospital infection-control precautions reduce the chance of spread. Meningococcal bacteria generally stop being contagious after effective antibiotics have been given for an appropriate period, but the hospital or public health team decides when precautions can end.
Meningococcemia can disrupt circulation throughout the body. Septic shock occurs when blood pressure and blood flow fall to dangerously low levels.
The infection may also cause disseminated intravascular coagulation, or DIC. In DIC, abnormal clotting uses up platelets and clotting proteins, leading to both tiny blood clots and bleeding. A severe purple skin rash linked to clotting and tissue damage is called purpura fulminans.
Possible complications include:
Some complications improve during recovery. Others can lead to long-term disability. Despite emergency treatment, meningococcemia can be fatal.
Vaccination lowers the risk of several types of meningococcal infection, but no vaccine protects against every strain. Different vaccines cover different groups of meningococcal bacteria, including MenACWY and MenB vaccines.
Which vaccines are offered depends on age, medical risk, travel, previous vaccination, and the immunization program where you live. People without a working spleen, those with certain complement disorders, and those taking complement-blocking medicines may need specific protection.
When a case is confirmed or strongly suspected, public health professionals identify close contacts. These contacts may be offered preventive antibiotics to remove bacteria from the nose and throat. They may also be offered vaccination in some outbreak or exposure situations.
Preventive antibiotics are not normally needed after brief or casual contact. Someone who shared a household, had intimate contact, or was directly exposed to saliva or respiratory secretions should follow public health advice promptly.
Avoiding shared drinks, smoking devices, or utensils that have direct saliva on them may reduce exposure. However, meningococcemia cannot always be prevented because bacteria may be carried without symptoms and infection can occur without a known exposure.
Meningococcemia is an acute infection, not a condition that usually remains active for years. Antibiotics can clear the bacteria, but recovery from inflammation and organ damage may take weeks or months.
Many survivors gradually return to school, work, exercise, and their usual activities. Early in recovery, tiredness, weakness, poor concentration, sleep changes, reduced appetite, and muscle pain can occur. Progress may be uneven rather than steady.
Follow-up is shaped by what happened during the illness. It may include checks of kidney function, hearing, movement, skin healing, or circulation. Physical rehabilitation, prosthetic care, reconstructive surgery, or occupational therapy may be needed after serious tissue or limb damage.
A sudden life-threatening illness can also affect emotional health. Anxiety, low mood, nightmares, or fear of another infection may occur in survivors and family members. These concerns deserve support, especially when they interfere with sleep, relationships, school, or work.
Having meningococcemia once does not guarantee protection against every meningococcal strain. Vaccination needs should be reviewed after recovery. Repeated invasive infections may lead to testing for an underlying immune or spleen problem.
Call emergency services now if you or someone else has a fever or suspected infection and is rapidly becoming very unwell, especially with:
Do not wait for every symptom or for a rash to appear. If the person is severely unwell, use emergency transport rather than driving them yourself.
After discharge, seek urgent medical advice for a new fever, worsening breathlessness, reduced urine, increasing wound redness, new skin discoloration, or a sudden decline in alertness.
Routine follow-up is appropriate for persistent fatigue, pain, sleep problems, scars, difficulty returning to usual activities, or emotional symptoms that are not rapidly worsening.
Is meningococcemia the same as meningitis?
No. Meningococcemia affects the bloodstream and circulation. Meningitis affects the lining around the brain and spinal cord. Both are caused by meningococcal bacteria, and they can occur together.
Is meningococcemia contagious?
The bacteria can spread through close contact with saliva or respiratory secretions. The bloodstream condition itself is not passed from person to person. Public health teams assess close contacts and arrange preventive antibiotics when needed.
Can you have meningococcemia without a rash?
Yes. The rash may develop late or never appear. Rapid worsening, cold limbs, severe pain, confusion, breathing changes, or unusual sleepiness can be warning signs even when the skin looks normal.
Can meningococcemia be cured?
Prompt antibiotics can clear the bacterial infection. Supportive hospital care treats shock and organ problems while the body recovers. Some people recover fully, while others have lasting effects from tissue or organ damage.
Can a vaccinated person still get meningococcemia?
Yes, although vaccination reduces the risk from the meningococcal groups it covers. Vaccines do not cover every strain, and protection may not be complete. Emergency symptoms still require immediate attention regardless of vaccination history.
How quickly does meningococcemia develop?
It can progress over hours. Early symptoms may look like a routine viral infection, but the person may become much sicker quickly. Rapid deterioration is one reason emergency assessment and early antibiotics are essential.
sofidex [Internet]. Daloreum; c2026. Meningococcemia; [reviewed 2026 Aug 20; cited 2026 Nov 10]. Available from: https://sofidex.com/patients/conditions/meningococcemia
sofidex. (2026, August 20). Meningococcemia. Daloreum. Retrieved November 10, 2026, from https://sofidex.com/patients/conditions/meningococcemia
Meningococcemia. sofidex. Reviewed August 20, 2026. Accessed November 10, 2026. https://sofidex.com/patients/conditions/meningococcemia
The cited date is today’s, because a citation records when you read the page. The reviewed date is when a clinician last checked it.